Marcel A.M. Beijk

Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin

Richard G. IJzerman, Renate T. de Jongh, Marcel A.M. Beijk et al. · European Journal of Clinical Investigation · 2003 · 276 citations

Medicine, Cardiology, Dermatology +17

A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis

Jan Baan, Bimmer E. Claessen, Kirsten Boerlage‐van Dijk et al. · JACC: Cardiovascular Interventions · 2017 · 140 citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +14

Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions

Bimmer E. Claessen, Marcel A.M. Beijk, Victor Legrand et al. · Circulation Cardiovascular Interventions · 2009 · 124 citations · Full text

Medicine, Cardiology, Surgery +17

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

Marcel A.M. Beijk, Margo Klomp, Niels Verouden et al. · European Heart Journal · 2009 · 121 citations · Full text

Medicine, Cardiology, Cell Therapy +12

Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry

Coen Boerhout Boerhout, Guus A. de Waard, Joo Myung Lee et al. · EuroIntervention · 2022 · 119 citations · Full text

Medicine, Cardiology, Clinical Sciences +16